Related references
Note: Only part of the references are listed.Patients with major depressive disorder have lower cerebral serotonin 4 receptor binding than healthy controls
K. Koehler-Forsberg et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2020)
Maximum Tolerated Dose Evaluation of the AMPA Modulator Org 26576 in Healthy Volunteers and Depressed Patients
Kari R. Nations et al.
Drugs in research & development (2013)
A Translational Approach to Evaluate the Efficacy and Safety of the Novel AMPA Receptor Positive Allosteric Modulator Org 26576 in Adult Attention-Deficit/Hyperactivity Disorder
Lenard A. Adler et al.
BIOLOGICAL PSYCHIATRY (2012)
The size and burden of mental disorders and other disorders of the brain in Europe 2010
H. U. Wittchen et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2011)
Effects of Two Selective Serotonin Reuptake Inhibitor Antidepressants, Sertraline and Escitalopram, on Aldosterone/Renin Ratio in Normotensive Depressed Male Patients
Ashraf H. Ahmed et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
A cognitive neuropsychological model of antidepressant drug action
A. Pringle et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2011)
Translational PK-PD modelling of molecular target modulation for the AMPA receptor positive allosteric modulator Org 26576
Roberta Bursi et al.
PSYCHOPHARMACOLOGY (2011)
The change of prefrontal QEEG theta cordance as a predictor of response to bupropion treatment in patients who had failed to respond to previous antidepressant treatments
Martin Bares et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2010)
The ampakine, Org 26576, bolsters early spatial reference learning and retrieval in the Morris water maze: a subchronic, dose-ranging study in rats
Eugene Hamlyn et al.
BEHAVIOURAL PHARMACOLOGY (2009)
The effect of serotonergic and noradrenergic antidepressants on face emotion processing in depressed patients
Richard Tranter et al.
JOURNAL OF AFFECTIVE DISORDERS (2009)
Effectiveness of a quantitative electroencephalographic biomarker for predicting differential response or remission with escitalopram and bupropion in major depressive disorder
Andrew F. Leuchter et al.
PSYCHIATRY RESEARCH (2009)
Comparative effectiveness of biomarkers and clinical indicators for predicting outcomes of SSRI treatment in Major Depressive Disorder: Results of the BRITE-MD study
Andrew F. Leuchter et al.
PSYCHIATRY RESEARCH (2009)
Chronic treatment with AMPA receptor potentiator Org 26576 increases neuronal cell proliferation and survival in adult rodent hippocampus
Xiaowei W. Su et al.
PSYCHOPHARMACOLOGY (2009)
Serum brain-derived neurotrophic factor, depression, and antidepressant medications: Meta-analyses and implications
Srijan Sen et al.
BIOLOGICAL PSYCHIATRY (2008)
Cellular mechanisms underlying the antidepressant effects of ketamine:: Role of α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors
Sungho Maeng et al.
BIOLOGICAL PSYCHIATRY (2008)
Early reduction in prefrontal theta QEEG cordance value predicts response to venlafaxine treatment in patients with resistant depressive disorder
Martin Bares et al.
EUROPEAN PSYCHIATRY (2008)
Changes in BDNF serum levels in patients with major depression disorder (MDD) after 6 months treatment with sertraline, escitalopram, or venlafaxine
Francesco Matrisciano et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2008)
A placebo-controlled add-on trial of the Ampakine, CX516, for cognitive deficits in schizophrenia
Donald C. Goff et al.
NEUROPSYCHOPHARMACOLOGY (2008)
Increased levels of glutamate in brains from patients with mood disorders
Kenji Hashimoto et al.
BIOLOGICAL PSYCHIATRY (2007)
Org 26576, a novel positive allosteric modulator, potentiates AMPA receptor responses in hippocampal neurones
G. Erdemli et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2007)
AMPA receptor potentiators: Application for depression and Parkinson's disease
Michael J. O'Neill et al.
CURRENT DRUG TARGETS (2007)
Pharmacology of ampakine modulators: From AMPA receptors to synapses and behavior
A. C. Arai et al.
CURRENT DRUG TARGETS (2007)
VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressants
Jennifer L. Warner-Schmidt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Low cerebrospinal fluid glutamate and glycine in refractory affective disorder
Mark A. Frye et al.
BIOLOGICAL PSYCHIATRY (2007)
Projections of global mortality and burden of disease from 2002 to 2030
Colin D. Mathers et al.
PLOS MEDICINE (2006)
Reliability and validity of a computerized neurocognitive test battery, CNS Vital Signs
C. Thomas Gualtieri et al.
ARCHIVES OF CLINICAL NEUROPSYCHOLOGY (2006)
Correlation between plasma levels of glutamate, alanine and serine with severity of depression
Hideaki Mitani et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2006)
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression
Carlos A. Zarate et al.
ARCHIVES OF GENERAL PSYCHIATRY (2006)
A role for AMPA receptors in mood disorders
A Alt et al.
BIOCHEMICAL PHARMACOLOGY (2006)
Glutamate-based therapeutic approaches: ampakines
G Lynch
CURRENT OPINION IN PHARMACOLOGY (2006)
Endophenotypes for psychiatric disorders: ready for primetime?
Carrie E. Bearden et al.
TRENDS IN GENETICS (2006)
Role of excitatory amino acids in the control of growth hormone secretion
E Aguilar et al.
ENDOCRINE (2005)
Modulation of synaptic plasticity by antimanic agents: The role of AMPA glutamate receptor subunit 1 synaptic expression
J Du et al.
JOURNAL OF NEUROSCIENCE (2004)
Derivation of a definition of remission on the Montgomery-Asberg depression rating scale corresponding to the definition of remission on the Hamilton rating scale for depression
M Zimmerman et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2004)
Chronic elevation of brain-derived neurotrophic factor by ampakines
JC Lauterborn et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
The 16-item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): A psychometric evaluation in patients with chronic major depression
AJ Rush et al.
BIOLOGICAL PSYCHIATRY (2003)
Chronic AMPA receptor potentiator (LY451646) treatment increases cell proliferation in adult rat hippocampus
F Bai et al.
NEUROPHARMACOLOGY (2003)
Coupling of theta activity and glucose metabolism in the human rostral anterior cingulate cortex: An EEG/PET study of normal and depressed subjects
DA Pizzagalli et al.
PSYCHOPHYSIOLOGY (2003)
The impact of treatment-resistant depression on health care utilization and costs
WH Crown et al.
JOURNAL OF CLINICAL PSYCHIATRY (2002)
Preliminary experience with an ampakine (CX516) as a single agent for the treatment of schizophrenia: a case series
S Marenco et al.
SCHIZOPHRENIA RESEARCH (2002)
Early changes in prefrontal activity characterize clinical responders to antidepressants
IA Cook et al.
NEUROPSYCHOPHARMACOLOGY (2002)
Antidepressant activity of memory-enhancing drugs in the reduction of submissive behavior model
RJ Knapp et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2002)
Decreased serum brain-derived neurotrophic factor levels in major depressed patients
F Karege et al.
PSYCHIATRY RESEARCH (2002)
Changes in brain function of depressed subjects during treatment with placebo
AF Leuchter et al.
AMERICAN JOURNAL OF PSYCHIATRY (2002)
A placebo-controlled pilot study of the ampakine CX516 added to clozapine in schizophrenia
DC Goff et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2001)
Antidepressant-like actions of an AMPA receptor potentiator (LY392098)
X Li et al.
NEUROPHARMACOLOGY (2001)
Regulation of BDNF expression in primary neuron culture by LY392098, a novel AMPA receptor potentiator
B Legutko et al.
NEUROPHARMACOLOGY (2001)
Comparison of the effects of ketamine and memantine on prolactin and cortisol release in men: A randomized, double-blind, placebo-controlled trial
N Hergovich et al.
NEUROPSYCHOPHARMACOLOGY (2001)
Cognitive deficits in depression - Possible implications for functional neuropathology
MP Austin et al.
BRITISH JOURNAL OF PSYCHIATRY (2001)
Antidepressant effects of ketamine in depressed patients
RM Berman et al.
BIOLOGICAL PSYCHIATRY (2000)
Share Paper
